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and sarcomatous component. It may arises de novo or on a pre-existing pleomorphic adenoma.
We present a case of parotid carcinosarcoma, exhibiting features of salivary ductal adenocar-
cinoma (carcinomatous element) and fibrosarcoma/osteosarcoma (sarcomatous element).
Immunohistochemical analysis with Ki67, p53, p27, C-KIT, bcl2, cerbB2, SMA, VIM has per-
formed and cell adhesion molecules’ expression, E-cadherin, beta4-integrin, desmoglein-2,
CD44s and ICAM-1 has been detected. In conclusion carcinosarcoma is an aggressive tumor, with
a biphasic malignant neoplastic component showing characteristic immunohistochemical pro-
file and reduced or extremely alternative CAMs expression.c 2005 Elsevier Ltd. All rights reserved.
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dIntroduction
Carcinosarcoma (CRS) (true malignant mixed tumor) is a
rare tumor, comprising 0.04–0.16% of all salivary gland741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reserved
oi:10.1016/j.ooe.2005.10.004
* Corresponding author. Tel./fax: +30 2310833760.
E-mail address: akpoul@yahoo.gr (A. Poulopoulos).tumors.1 Carcinosarcoma is a biphasic neoplasm in which
both the epithelial and mesenchymal component reveal
features of malignancy.2 The majority of cases manifested
epithelial element as salivary ductal carcinoma, but adeno-
carcinoma, squamous cell carcinoma, adenoid-cystic and
undifferentiated carcinoma have also been identified.3 On
the other hand, the sarcomatous component is most often.
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fibrosarcoma, myxosarcoma, malignant fibrous histiocy-
toma and even liposarcoma also have been described.4 In
most tumors the two components are intermixed, but occa-
sionally the carcinoma and sarcoma elements occur adja-
cent to one another.
A case of parotid CRS is examined immunohistochemi-
cally, focusing on mitotic activity, cell cycle regulation
and alterations of cell adhesion molecules’ expression.Case report
A 73 year-old male presented with a complaint of swelling
involved the left parotid that had enlarged rapidly in
6 months. The patient had no history of tobacco or alcohol
abuse or prior exposure to radiotherapy for any malignancy
and by clinical examination a partial facial palsy was ob-
served. No neck masses or palpable lymph nodes were no-
ticed. After total parotid excision, in Red Cross Hospital,
Athens Greece, the tumor was histologically examined with
hematoxylin–eosin revealing a high malignant carcinosar-
coma of parotid consisted of carcinomatous and sarcoma-
tous elements (Fig. 1a–c). The carcinomatous part was
composed by pleomorphic neoplastic cells with large hyper-Figure 1 Microscopic findings. (a) Carcinomatous component of
type necrosis as salivary ductal carcinoma (H + E·300). (b) Intermix
of sarcomatous component (H + E·300). (c) Sarcomatous compon
(H + E·400).
Figure 2 Immunohistochemistry. (a) Ki67: Strong positivity in m
sarcomatous component (Envision/HRP·100). (b) cerbB2 (HER-2/
(Envision/HRP·300). (c) p27: Characteristic positivity only at the o
(Envision/HRP·300).chromatic nuclei exhibiting high mitotic activity, scanty
cytoplasm, arranged in solid, trabecular and mainly ductal
structures with central comedo-type necrosis, giving the
appearance of salivary ductal carcinoma. On the other
hand, high grade sarcomatous component was consisting
of spindle and pleomorphic cells with a high mitotic rate
giving the picture of fibrosarcoma. Highly pleomorphic giant
multinucleated cells with atypical mitotic figures resem-
bling malignant fibrous histiocytoma and osteosarcoma.
Necrosis and perineural and vascular invasion were also ob-
served, while structures of coexisting pleomorphic adenoma
and remnants of fibrous capsule were also existed.
Immunohistochemical studies included staining with
Ki67, p53, p27, C-KIT, bcl2, cerbB2, SMA, VIM, AE1/
AE3 (pancytokeratin) (DakoCytomation A/S, Glostrup,
Denmark), and CAMs E-cadherin, beta4-integrin, desmog-
lein-2, CD44s and ICAM-1 (Santa Cruz, Biotechnology Inc.,
California, USA) in 3 lm slides sections of paraffin-embed-
ded parotid tissue using an Envision/HRP immunohisto-
chemical technique in ChemMate/TechMate Detection
System Autostainer (DakoCytomation A/S, Glostrup,
Denmark) according to manufacturers instructions.
Ki67 (Fig. 2a) and p53 were positive in more than 50%
of neoplastic in both carcinomatous and sarcomatous com-
ponents. CerbB2/HER2(neu) were strongly expressed incarcinosarcoma: Large ductal structures with central comedo-
ed remnants of duct-like forms and spindle mesenchymal cells
ent: Multinucleated giant cells with bizarre mitotic activity
ore than 50% of neoplastic cells in both carcinomatous and
neu): Positivity in epithelial component of ductal structures
uter periphery of ductal structures and normal salivary tissue
Figure 3 Cell adhesion molecules. (a) beta4-Integrin: Weak expression in epithelial element (Envision/HRP·300). (b) E-cadherin:
Reduced expression only in the carcinomatous component (Envision/HRP·300). (c) CD44s: Focal characteristic expression in both
epithelial and mesenchymal neoplastic elements (Envision/HRP·300). (d) ICAM-1: Focal positivity in epithelial element and diffuse
in mesenchymal cells (Envision/HRP·300).
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tive only in cells at the periphery of glandular/ductal
structures and the whole adjacent normal salivary gland
parenchyma (Fig. 3c). C-KIT (CD117) was focally expressed
only in some epithelial cells of carcinomatous element,
instead of a general diffuse positivity for pancytokeratins
and bcl-2 in this component. On the other hand, sarcoma-
tous component and modified myoepithelial-type neo-
plastic cells surrounding glandular structures showed
immunoreactivity for bcl-2, VIM and SMA. The expression
of cell adhesion molecules revealed a characteristic man-
ner including weak expression of beta4-integrin (Fig. 3a)
and desmoglein-2, weak to moderate membranic positivity
for E-cadherin especially in ductal structures (Fig. 3b),
very focal staining for CD44s (Fig. 3c) in both carcinoma
(luminal cells besides comedo-necrosis) and sarcomatous
areas, and diffuse cytoplasmic focal pattern of ICAM-I in
epithelial cells of ductal structures and mesenchymal sar-
comatous cells (Fig. 3d).Discussion
CRS of the parotid gland affects mainly patients in the fifth
decade of life, without gender predilection and pain or fa-
cial palsy follows a suddenly increased neck mass.5
Immunohistochemical and ultrastructural studies support
the idea of a monoclonal origin of this type of neoplasm
with a common stem cell that could be myoepithelial cell,6
while other authors favour an epithelial histogenesis so that
the term sarcomatoid carcinoma thought to be more appro-
priate.7 In our case, the SMA positive cells at the outerperiphery of ductal structures were also positive for p27
indicating a cell cycle normal regulation similar to normal
salivary tissue, instead of the rest of neoplastic cells whose
negative expression indicated a cell cycle abnormality and
unchecked proliferation. This finding, together with the
observations that cerbB2 were strongly positive in epithelial
SMA/VIM (-) cells and that Ki67/p53 were expressed in both
carcinomatous and sarcomatous elements suggested a
multipotential capacity of cell proliferation and a synchro-
nous dual ductal–luminal epithelial and myoepithelial origin
for carcinosarcoma similarly to pleomorphic adenoma
pathogenesis.8
As the tumor grows, invasion and metastasis starts with
the detachment of tumor cells from their neighbors, fol-
lowed by their migration to the extracellular matrix and
finally inoculation into the new environment. For these pur-
poses disruption of cell–cell and cell–substrate interactions
is required.9 E-cadherin in adherens junctions and desmo-
glein-2 in glandular desmosomes showed moderate to
extreme reduction in our case, playing a critical role in
tumor dedifferentiation and metastasis. Also, the weak
cytoplasmic and unpolarized expression of beta4-integrin
that we observed in the current study, helps the tumor cells
to migrate by crawl via laminin in the stroma.10 Although,
CD44s receptor of hyaluronan has been described as strongly
expressed in pleomorphic adenomas, in carcinosarcoma we
revealed only a focal positivity in luminal cells besides com-
edo-necrosis and weakly in sarcoma lesions. Finally, a focal
positivity in epithelial structures and diffuse in mesenchy-
mal component for ICAM-1was detected supporting the high
invasive capacity of this tumor similarly to other neoplasms
of salivary origin.11
Carcinosarcoma of the parotid gland 143In conclusion, we have described a case of parotid
carcinosarcoma (true malignant tumor) that was consisted
of salivary ductal carcinoma and fibrosarcoma with features
of osteosarcoma and malignant histiocytoma. In the best of
our knowledge p27 and cerbB2 biomarkers and cell adhesion
molecules have never been detected in carcinosarcoma
before. According to our results, the carcinomatous and
sarcomatous components may be derived from both epithe-
lial and modified myoepithelial cells and qualitative and
quantitative alterations of cell adhesion molecules possibly
play a critical role in tumor genesis, development and
invasion.Acknowledgements
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